Susquehanna International Group
ENTX icon

Susquehanna International Group’s Entera Bio ENTX Stock Holding History

Susquehanna International Group’s Portfolio ENTX Stock Details ENTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-35,700
Closed -$101K – 13209
2021
Q4 		$101K Sell
35,700
-24,400
-41% -$91.4K ﹤0.01% 12144
2021
Q3 		$283K Sell
60,100
-32,000
-35% -$164K ﹤0.01% 10727
2021
Q2 		$551K Buy
+92,100
New +$340K ﹤0.01% 9354

Other funds holding ENTX

KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PHP
Parkman Healthcare Partners Stamford, Connecticut $970M AUM 79.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
SFCM
Seven Fleet Capital Management Mountain View, California $318M AUM
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return
SEIA
Signature Estate & Investment Advisors Los Angeles, California $5.56B AUM 26.66% 1-Year Est. Return

Susquehanna International Group's ENTX Position: Q1 2026 in Review

Susquehanna International Group sold out of Entera Bio (ENTX) in Q1 2026, closing a stake of 64,910 shares — an estimated $126K sold.

Susquehanna International Group first reported a position in ENTX in Q2 2021 and held it in 9 quarters. The position peaked at $399K in Q2 2021. 26 funds tracked by Wall St. Rank hold ENTX as of Q1 2026.

  • Susquehanna International Group reported no remaining Entera Bio position as of Q1 2026 after selling out during the quarter.
  • Susquehanna International Group sold 64,910 Entera Bio shares in Q1 2026, an estimated $126K.
  • Susquehanna International Group first reported a position in Entera Bio in Q2 2021 and held it in 9 quarters.
  • Susquehanna International Group's Entera Bio position peaked at $399K in Q2 2021.
  • 26 funds tracked by Wall St. Rank held Entera Bio as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.